[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364298-105":59,"doc-detail-364298-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-and-bulk-rna-sequencing-analysis-reveals-cenpa-as-a-potential-biomarker-and-therapeutic-target-in-cancers","Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers","","Pan-cancer bioinformatic work evaluates Centromere Protein A (CENPA), a variant of histone H3, to clarify its roles in cell-cycle biology and cancer outcomes. Genome, transcriptome, and clinical data from public resources support analyses of CENPA alterations, expression, functional enrichment, stemness links, cellular localization, cell-cycle association, survival impact, and immune microenvironment relationships. A glioma prognostic model demonstrates biomarker utility, while drug sensitivity correlations and protein-ligand docking identify candidate therapeutics targeting CENPA.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-and-bulk-rna-sequencing-analysis-reveals-cenpa-as-a-potential-biomarker-and-therapeutic-target-in-cancers/364298/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-and-bulk-rna-sequencing-analysis-reveals-cenpa-as-a-potential-biomarker-and-therapeutic-target-in-cancers/364298.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study on CENPA?","Question",{"text":112,"@type":113},"The study investigates CENPA as a potential biomarker and therapeutic target across cancers by integrating single-cell and bulk RNA sequencing analyses with clinical and public genomic resources.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which types of analyses are used to characterize CENPA?",{"text":117,"@type":113},"Analyses include genetic alterations, mRNA expression, functional enrichment, stemness association, mutation and expression patterns across cell populations and locations, links to the cell cycle, survival impact, and association with the immune microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the researchers validate biomarker and therapeutic potential?",{"text":121,"@type":113},"They develop a prognostic model for glioma to show CENPA’s biomarker value and use drug sensitivity correlations plus protein-ligand docking to predict drugs that may target CENPA in cancer cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364298,1790931621,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","PLOS ONE  \nOPEN ACCESS  \nCitation: Liu H, Karsidag M, Chhatwal K, Wang P, Tang T (2025) Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoSONE 20(1): e0314745 . [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0314745](journal.pone.0314745)  \nEditor: Zhiming Li, Sichuan University, CHINA  \nReceived: September 3, 2024  \nAccepted: November 14, 2024  \nPublished: January 16, 2025  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here:  \n[https://doi.org/10.1371/journal.pone.0314745](https://doi.org/10.1371/journal.pone.0314745)  \n[Copyright:](Copyright:) © [2025](2025) Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: The data underlying the results presented in the study are available from open database.  \nFunding: This study was supported by funding from the K. C. Wong Education Foundation, the  \nRESEARCH ARTICLE  \nSingle-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers  \nHengrui Liu1,2, Miray Karsidag3, Kunwer Chhatwal4, Panpan Wang5 *, Tao Tang6 *  \n1 Cancer Research Institute, Jinan University, Guangzhou, Guangdong, China, 2 Yinuo Biomedical Co. , Ltd, Tianjin, China, 3 Canyon Crest Academy, San Diego, CA, United States of America, 4 Hopkinton High School, Hopkinton, MA, United States of America, 5 The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China, 6 SunYat-Sen University Cancer Center, Guangzhou, Guangdong, China  \n* [tangtao@sysucc.org.cn](tangtao@sysucc.org.cn) (TT); [wangpp@jnu.edu.cn](wangpp@jnu.edu.cn) (PW)  \nAbstract  \nBackground  \nCancer remains one of the most significant public health challenges worldwide. A widely recognized hallmark of cancer is the ability to sustain proliferative signaling, which is closely tied to various cell cycle processes. Centromere Protein A (CENPA), a variant of the standard histone H3, is crucial for selective chromosome segregation during the cell cycle. Despite its importance, a comprehensive pan-cancer bioinformatic analysis of CENPA has not yet been conducted.  \nMethods  \nData on genomes, transcriptomes, and clinical information were retrieved from publicly accessible databases. We analyzed CENPA’s genetic alterations, mRNA expression, functional enrichment, association with stemness, mutations, expression across cell populationsand cellular locations, link to the cell cycle, impact on survival, and its relationship with the immune microenvironment. Additionally, a prognostic model for glioma patients was developed to demonstrate CENPA’s potential as a biomarker. Furthermore, drugs targeting CENPA in cancer cells were identified and predicted using drug sensitivity correlations and protein-ligand docking.  \nResults  \nCENPA exhibited low levels of gene mutation across various cancers. It was found to be overexpressed in nearly all cancer types analyzed in TCGA, relative to normal controls, and was predominantly located in the nucleus of malignant cells. CENPA showed a strong association with the cancer cell cycle, particularly as a biomarker for the G2 phase. It also emerged as a valuable diagnostic and prognostic biomarker across multiple cancer types. In glioma, CENPA demonstrated reliable prognostic potential when used alongside other prognostic factors. Additionally, CENPA was linked to the immune microenvironment.  \nNatural Science Foundation of China (81603342) awarded to PW, the Guangdong Basic and Applied Basic Research Fo","cbCaibRlFMTEBzSN","https://ap.wps.com/l/cbCaibRlFMTEBzSN","pdf",4331074,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main focus of this study on CENPA?\",\"answer\":\"The study investigates CENPA as a potential biomarker and therapeutic target across cancers by integrating single-cell and bulk RNA sequencing analyses with clinical and public genomic resources.\"},{\"question\":\"Which types of analyses are used to characterize CENPA?\",\"answer\":\"Analyses include genetic alterations, mRNA expression, functional enrichment, stemness association, mutation and expression patterns across cell populations and locations, links to the cell cycle, survival impact, and association with the immune microenvironment.\"},{\"question\":\"How do the researchers validate biomarker and therapeutic potential?\",\"answer\":\"They develop a prognostic model for glioma to show CENPA’s biomarker value and use drug sensitivity correlations plus protein-ligand docking to predict drugs that may target CENPA in cancer cells.\"}]","Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers | PDF",1790156809,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c34f337080b8c44db59d1cfe70ad3076.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/250fdafffb8c2c161eb17d3a58b55efc.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1da64c849dd7048d899b4b6df369ff78.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b69c7e98501d324182052160cb3222f0.webp",980,1268]